Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0215109
Abstract: The original underlying data supporting results in this article are no longer available. The authors replicated the experiments for which concerns were raised using the same methods and conditions as in the original study [1].… read more here.
Keywords: activity sorafenib; sorafenib human; antitumor activity; expression concern ... See more keywords